Anti-PCSK9 antibodies for the treatment of heterozygous familial hypercholesterolemia: patient selection and perspectives

Heterozygous familial hypercholesterolemia (FH) is a genetic disorder characterized by high low-density lipoprotein cholesterol levels from birth, which exposes the arteries to high levels of atherogenic lipoproteins lifelong and results in a significantly increased risk of premature cardiovascular...

Descripción completa

Detalles Bibliográficos
Autores principales: Catapano, Alberico Luigi, Pirillo, Angela, Norata, Giuseppe Danilo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5590683/
https://www.ncbi.nlm.nih.gov/pubmed/28919772
http://dx.doi.org/10.2147/VHRM.S130338

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5590683/
https://www.ncbi.nlm.nih.gov/pubmed/28919772
http://dx.doi.org/10.2147/VHRM.S130338

Ejemplares similares